MiNA Therapeutics
Susan has over 25 years of finance experience in life sciences and investment banking, including as Managing Director of Equity Capital Markets at Citigroup Global Markets Limited and Managing Director at Torreya Partners LLC. Susan currently sits on the Board of Directors of several Life Science companies including Scancell Holdings, Evgen Pharma and Exploristics. Susan is also Corporate Finance Advisor for Theolytics and an Advisor for Oxford Sciences Enterprises.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
MiNA Therapeutics
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.